Intervention: Pharmacological intervention

This refers to the drug, therapy, or factor being studied in a clinical trial or observational study. Examples include antiviral agents monoclonal antibodies, corticosteroids, vaccines and other pharmacological agents

Mazzitelli 2

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Merad

France
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Monkey vax

France
|
2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Non-hospital health centre
  • Vaccination centre
  • Monkeypox virus
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Montalti

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Non-hospital health centre
  • Vaccination centre
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination

Montero Morales

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Non-hospital health centre
  • Vaccination centre
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination

Kuzubov

Russian Federation
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination
  • VAC∆6

Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Pharmacological intervention
  • Monoclonal antibodies
  • Temelimab

ESOA-19

Portugal
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Evans

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Molnupiravir
  • Sotrovimab

Fontàn-Vela

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Franke

Germany
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Pharmacological intervention
  • Corticosteroid
  • Methylprednisolone

COVA / RestPlus

The Netherlands
|
2022-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Healthcare workers
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination
  • MVA-BN